EMD-55789

Single-particle
3.54 Å
EMD-55789
3D View Gallery
Deposition: 21/11/2025
Map released: 22/07/2026
Last modified: 22/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-55789
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
EMICSS annotations (xml)

Structure of vaccine candidate AHSV-4 VP2 DI-mi3 nanoparticle

EMD-55789

Single-particle
3.54 Å
EMD-55789
3D View Gallery
Deposition: 21/11/2025
Map released: 22/07/2026
Last modified: 22/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Thermotoga maritima, African horse sickness virus 4
Sample: SC003-mi3 nanoparticles conjugated with AHSV-4 VP2 DI-SpyTag antigen

Deposition Authors: Martinez-Castillo A , Aebischer A, Fu L , Breard E , Zientara S , Kortekaas J , Beer M , Abrescia NGA
Cryo-EM structure of African horse sickness virus VP2 receptor-binding protein enables nanoparticle vaccine design.
Martinez-Castillo A , Aebischer A, Toneatti P, Fu L , Vitour D, Sailleau C, Hoffmann B, Franzke K, Eschbaumer M, Weber S, Calvo Pinilla E, Ortego J, Gil-Carton D, Breard E , Zientara S , Kortekaas J , Beer M , Abrescia NG
(2026) Nat Commun
PUBMED: 42401561
DOI: doi:10.1038/s41467-026-75067-9
ISSN: 2041-1723
Grant Support: